To assess the potential beneficial effects of vasodilator agents in patients with severe mitral regurgitation, sodium nitroprusside was administered intravenously at a rate of 16 to 100 ,Dg/min in eight patients with clinically significant mitral regurgitation presumably due to dysfunction of the subvalvar apparatus. In all patients there was a decrease in the magnitude of the peak 'V' wave (from 50 + 4.5 to 19 2.9 mm Hg) and in left ventricular filling pressure (33 + 1.8 to 16 + 1.4 mm Hg), together with a decreased intensity of the apical pansystolic murmur. There was a significant increase in forward cardiac index (2.2 + 3.5 to 3.3 + .47 liter/min/M2) and forward stroke volume index (23 4.4 to 36 + 6.6 ml/M2) along with a reduction in systemic vascular resistance (1802 331 to 1102 241 dynes/sec/cm-5). In the five patients in whom the therapy was continued, relief of symptoms of pulmonary venous congestion occurred. In the four patients in whom left ventricular volumes were determined angiographically, the observed increase in forward stroke volume was due to a reduction in the regurgitant fraction. These findings suggest that the use of vasodilator agents like nitroprusside can achieve the major objectives of treatment of patients with mitral regurgitation: an increase in forward stroke output, a reduction in regurgitant volume and a decrease in pulmonary venous pressure.
SUMMARY
To assess the potential beneficial effects of vasodilator agents in patients with severe mitral regurgitation, sodium nitroprusside was administered intravenously at a rate of 16 to 100 ,Dg/min in eight patients with clinically significant mitral regurgitation presumably due to dysfunction of the subvalvar apparatus. In all patients there was a decrease in the magnitude of the peak 'V' wave (from 50 + 4.5 to 19 2.9 mm Hg) and in left ventricular filling pressure (33 + 1.8 to 16 + 1.4 mm Hg), together with a decreased intensity of the apical pansystolic murmur. There was a significant increase in forward cardiac index (2.2 + 3.5 to 3.3 + .47 liter/min/M2) and forward stroke volume index (23 4.4 to 36 + 6.6 ml/M2) along with a reduction in systemic vascular resistance (1802 331 to 1102 241 dynes/sec/cm-5). In the five patients in whom the therapy was continued, relief of symptoms of pulmonary venous congestion occurred. In the four patients in whom left ventricular volumes were determined angiographically, the observed increase in forward stroke volume was due to a reduction in the regurgitant fraction. These findings suggest that the use of vasodilator agents like nitroprusside can achieve the major objectives of treatment of patients with mitral regurgitation: an increase in forward stroke output, a reduction in regurgitant volume and a decrease in pulmonary venous pressure.
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Outflow impedance Total stroke volume Regurgitant volume SURGICAL REPAIR or replacement of the mitral valve apparatus can markedly benefit selected patients with severe and symptomatic mitral regurgitation. However, clinicians sometimes encounter situations where surgical therapy involves a prohibitively high risk and should be deferred. For example, in patients developing severe mitral regurgitation following acute myocardial infarction, the operative mortality associated with mitral valve replacement in the immediate postinfarction period is high, and a significantly better prognosis can be expected if surgical therapy can be deferred for a few weeks. [1] [2] [3] In patients with mitral regurgitation, increased systemic vascular resistance augments the regurgitation. 4 associated with increased forward output and decreased regurgitant volume. That a decrease in regurgitant volume occurred was apparent from the reduction in intensity of the apical pansystolic murmur, and from the marked decrease in the magnitude of the V' wave in the pulmonary capillary wedge pressure tracing. Finally, in all four patients in whom regurgitant volume was calculated, it was significantly reduced during nitroprusside infusion. Decreased regurgitant volume in these patients, however, might not be entirely due to decreased aortic impedance to left ventricular ejection; increased competence of the mitral valve will also decrease the regurgitant volume.
That there might have been increased competence of the mitral valve in these patients was suggested by the increased systolic pressure gradient between the left ventricle and pulmonary capillary wedge pressure during nitroprusside infusion ( fig. 2) 
